Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXU29B
|
||||
| Drug Name |
N-{(S)-1-[2-(4-Isobutoxy-phenylamino)-ethylcarbamoyl]-3-methyl-butyl}-4-methoxy-benzamide
|
||||
| Synonyms |
CHEMBL58179
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C26H37N3O4
|
||||
| Canonical SMILES |
COc1ccc(cc1)C(=O)N[C@@H](CC(C)C)C(=O)NCCNc2ccc(OCC(C)C)cc2
|
||||
| InChI |
InChI=1S/C26H37N3O4/c1-18(2)16-24(29-25(30)20-6-10-22(32-5)11-7-20)26(31)28-15-14-27-21-8-12-23(13-9-21)33-17-19(3)4/h6-13,18-19,24,27H,14-17H2,1-5H3,(H,28,31)(H,29,30)/t24-/m0/s1
|
||||
| InChIKey |
UXKBFQZGWRNMCB-DEOSSOPVSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.